Organoids Market Size and Forecasts (2020 – 2030)

Organoids Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Organ Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Development of Biology Disease, Pathology of infectious Disease, Regenerative Medicines, Drug Discovery and Personalized Medicine, Drug Toxicity and Efficacy Testing, and Others), Source (Pluripotent Stem Cell and Organ Specific Adult Stem Cell), Type (Instruments, Consumables, and Services), and Geography

Send Enquiry
Item ID: TIPRE00017616 Category: Tags: , ,

$3,185$5,985

Description

The organoids market is expected to grow from US$ 2.507 billion in 2022 to US$ 12.206 billion by 2030; it is estimated to register a CAGR of 21.9% from 2022 to 2030. The higher demand for tumor modeling and biobanking, growing adoption of personalized drugs, and rising focus on developing alternatives for animal testing models drive the organoids market growth. The organoids market trends include combining organoids with organ-on-a-chip.

The organoids are tiny, self-organized, three-dimensional tissue cultures that are derived from stem cells. Such cultures can be crafted to replicate much of the complexity of an organ or to express selected aspects of it, like producing only certain types of cells. Organoids grow from stem cells—cells that can divide indefinitely and produce different types of cells as part of their progeny. Organoids can range in size from less than the width of a hair to five millimeters.

Many market players and research institutes operating in the organoids market are developing advanced technologies to expand their product portfolios and increase their market shares. A few of the recent developments related to organoids are mentioned below:

o In November 2020, Cellesce Ltd. entered a partnership with Manchester BIOGEL for the development of fully synthetic animal-free three-dimensional (3D) scaffolds that mimic the physiological environment in the human body and enable the manufacture, scale up, and improved reproducibility of patient-derived organoids.

o In November 2020, Cellesce Ltd. entered a partnership with Manchester BIOGEL for the development of fully synthetic animal-free three-dimensional (3D) scaffolds that mimic the physiological environment in the human body and enable the manufacture, scale up, and improved reproducibility of patient-derived organoids.

Thus, the development is likely to introduce new trends in the organoids market during the forecast period.

The increasing demand for new and advanced drugs is driving the overall pace of drug discovery and research. According to ClinicalTrials.gov, the total number of clinical trial studies in 2020 was estimated to be 356,282. A recent survey by the Hubrecht Institute states that organoids can potentially make expensive drugs more cost-effective by identifying patients who are not likely to benefit from the drug. An increasing number of clinical trials worldwide is expected to drive the demand for advanced medical technologies, including organoid models.

Further, organoids in drug discovery are not limited to just cancer, they are also used in other diseases, such as cystic fibrosis, polycystic kidney disease, microcephaly, and infectious diseases of the gut and airway. For instance, organoids can summarize the properties of an organ, such as organ structure and function. Also, organoids can restore a tissue or organ’s original genetic and epigenetic state, making them suitable for gene editing. Various studies have shown positive results of combining CRISPR-Cas9 technology with organoids, which has expanded opportunities for breakthroughs in cystic fibrosis. According to a study ‘CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank,’ published in 2020, a biobank of cystic fibrosis intestinal organoids represented 664 patients, and ~20% of them were theoretically able to efficiently repair nonsense mutations in the cystic fibrosis transmembrane conductor receptor through adenine base editors. Despite a few achievements of gene-edited organoids in some animal models, their efficiency is significantly low, and the success rate is not high. Therefore, it is crucial to research and develop a process for gene-edited organoids’ safety, long-term stability, and functionality.

Moreover, the COVID-19 pandemic triggered the need to develop human lung organoid models. For instance, MilliporeSigma developed a 3dGRO Human Lung Organoid Culture System that allows researchers to control, access, and reproduce organ tissue for culturing an organoid model of human lung epithelium that can aid in obtaining positive and successful results during their research.

Thus, such innovations are expected to offer more significant growth opportunities for organoids market growth.

Application-Based Insights

Based on application, the organoids market is divided into developmental biology, disease pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. In 2022, the developmental biology held the largest share of the market and drug discovery & personalized medicine is anticipated to register the highest CAGR during the forecast period.

Source-Based Insights

Based on source, the organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2022 and is expected to record at a higher CAGR during the forecast period.

The World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine are a few of the major primary and secondary sources referred to while preparing the report on the organoids market.

Type-Based Insights

Based on type, the organoids market is bifurcated into instruments, consumables, and services. The consumables segment held a larger share of the market in 2022 and is expected to record at a higher CAGR during the forecast period.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

Pluripotent Stem Cells Segment to Account for Largest and Fastest Growing Market Share by Source in Organoids Market during 2023–2030

According to our new research study on ” Organoids Market Forecast to 2030 – COVID-19 Impact and Global Analysis – by Organ Type, Application, Source, and Type,” the market is expected to grow from US$ 2.507 billion in 2022 to US$ 12.206 billion by 2030; it is estimated to register a CAGR of 21.9% from 2022 to 2030. The report highlights the key factors driving the organoids market growth and prominent players with their developments in the market.

Based on source, the organoids market is segmented into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held the larger share of the market in 2022 and is anticipated to register the higher CAGR in the market during the forecast period. Cells that can self-renew by dividing and developing into three primary groups of cells are known as pluripotent stem cells. The three primary groups of cells formed by the pluripotent cells make up a human body, including ectoderm (skin and nervous system) and endoderm (gastrointestinal and respiratory tracts, endocrine glands, liver, and pancreas). Induced pluripotent stem cells (iPSCs) are perceived as an essential resource for regenerative medicine to replace diseased or damaged tissues. iPSCs have numerous biomedical applications in fundamental research, drug screening, toxicological studies, disease modeling, and cell therapy. These cells can be potentially used in cell replacement therapy to treat patients with cellular diseases. Thus, they are widely used for developing an organoid in vitro. In addition, pluripotent cells are used in biobanking to preserve patient-derived stem cells in various applications, which can be used in research and therapeutics. In November 2017, Cincinnati Children’s scientists launched the Center for Stem Cell and Organoid Medicine (CuSTOM), which uses pluripotent stem cells to mimic organoids.

Based on the region, Asia Pacific is the fastest growing region in the organoids market. Among the countries accounted in the region for the study, Japan is holding the largest market share of the region in the organoids market.

Japan’s rapidly aging population presents unique business opportunities in health sciences as older people need more medicine. The government is responding by easing different life science regulations and accelerating innovative new drugs to promote current pharma companies, both domestic and foreign, and attract new companies. Successful preclinical efficacy studies with organoids generated from human adult stem cells (ASCs) or PSCs have led to several exciting programs aimed at therapeutic uses. For instance, Tokyo Medical and Dental University (TMDU) in Japan plans to conduct a first-inhuman trial of intestinal organoids for treatment against inflammatory bowel disease. In February 2022, TMDU developed a protocol to transplant 3D cellular structures that could regenerate damaged intestine. Currently, only one institution is geared toward PSC-derived organoid transplantation. The vascularized liver bud organoid transplantation initiative at the Yokohama City University (YCU) Advanced Medical Research Center was established to treat pediatric metabolic liver disease.

The market players in the country are focusing on organic and inorganic strategies for business development. In March 2019, Yamaha Motor Co., Ltd. entered into a collaborative research project with Hubrecht Organoid Technology (HUB, the Netherlands), a leading organoid research center. The collaboration aims to accelerate the development of technology and jointly analyze business opportunities in this field of research. Similarly, in August 2022, Cincinnati Children’s and the RIKEN Center for Biosystems Dynamics Research developed progenitor cells needed to build vital connective tissues for esophagi, livers, stomachs, and lung organoids. Thus, such strategies by the players based in Japan are expected to support the growth of the organoids market in the country over the forecast period.

STEMCELL Technologies Inc; Cellesce Ltd; Hubrecht Organoid Technology; Definigen; Organoid Therapeutics; PeproTech, Inc; Thermo Fisher Scientific Inc; Corning Inc; Merck KGaA, and InSphero. are among the key companies operating in the organoids market.

Organoids Market, by Source, 2022 (%)

Source:the research team Analysis

Companies operating in the organoids market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the organoids market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall organoids market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

A few of the significant developments by key organoids market players are listed below.

• In Apr-2023, InSphero AG announced that the company is making their patented Akura 96 and 384 Spheroid Microplates available to researchers in the Indian market by signing a distribution agreement with Bionova Supplies in the Biotechnology and Scientific Instruments field in India

• In Aug-2021, STEMCELL Technologies and Hubrecht Organoid Technology (HUB) have signed an agreement to use tissue-derived organoids—including lung, intestinal, and liver organoids—in preclinical toxicology screening and non-cancer drug development services to be offered by the Contract Assay Services division of STEMCELL.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Hair Removal Products Market, by Product Type
1.3.2 South & Central America Hair Removal Products Market, by End User
1.3.3 South & Central America Hair Removal Products Market, by Distribution Channel
1.3.4 South & Central America Hair Removal Products Market, by Country
2. Key Takeaways
3. Research Methodology
3.1 Scope of the Study
3.2 Research Methodology
3.2.1 Data Collection:
3.2.2 Primary Interviews:
3.2.3 Hypothesis formulation:
3.2.4 Macro-economic factor analysis:
3.2.5 Developing base number:
3.2.6 Data Triangulation:
3.2.7 Country level data:
4. South & Central America Hair Removal Products Market Landscape
4.1 Market Overview
4.2 Porter’s Five Forces Analysis
4.3 Ecosystem Analysis
4.4 Expert Opinion
5. South & Central America Hair Removal Products Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Demand for Men’s Hair Removal Products
5.1.2 Increased Spending on Personal Grooming Products
5.2 Market Restraints
5.2.1 Adoption of Permanent Hair Removal Methods
5.3 Market Opportunities
5.3.1 Development of Smart Hair Removal Devices
5.4 Future Trends
5.4.1 Preference for Natural and Clean-Label Hair Removal Products
5.5 Impact Analysis of Drivers and Restraints
6. Hair Removal Products – South & Central America Market Analysis
6.1 South & Central America Hair Removal Products Market Overview
6.2 South & Central America Hair Removal Products Market Forecast and Analysis
7. South & Central America Hair Removal Products Market Analysis – By Product Type
7.1 Overview
7.2 South & Central America Hair Removal Products Market, By Product Type (2021 and 2028)
7.3 Creams
7.3.1 Overview
7.3.2 Creams: South & Central America Hair Removal Products Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Wax Strips
7.4.1 Overview
7.4.2 Wax Strips: South & Central America Hair Removal Products Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Razors and Blades:
7.5.1 Overview
7.5.2 Razors and Blades: South & Central America Hair Removal Products Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Epilators:
7.6.1 Overview
7.6.2 Epilators: South & Central America Hair Removal Products Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others:
7.7.1 Overview
7.7.2 Others: South & Central America Hair Removal Products Market – Revenue and Forecast to 2028 (US$ Million)
8. South & Central America Hair Removal Products Market Analysis – By End User
8.1 Overview
8.2 South & Central America Hair Removal Products Market, By End User (2021 and 2028)
8.3 Men
8.3.1 Overview
8.3.2 Men: South & Central America Hair Removal Products Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Women
8.4.1 Overview
8.4.2 Women: South & Central America Hair Removal Products Market – Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Hair Removal Products Market Analysis – By Distribution Channel
9.1 Overview
9.2 South & Central America Hair Removal Products Market, By Distribution Channel (2021 and 2028)
9.3 Supermarkets and Hypermarkets
9.3.1 Overview
9.3.2 Supermarkets and Hypermarkets: South & Central America Hair Removal Products Market- Revenue and Forecast to 2028 (US$ Million)
9.4 Convenience Stores
9.4.1 Overview
9.4.2 Convenience Stores: South & Central America Hair Removal Products Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Online Retail
9.5.1 Overview
9.5.2 Online Retail: South & Central America Hair Removal Products Market- Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: South & Central America Hair Removal Products Market- Revenue and Forecast to 2028 (US$ Million)
10. South & Central America Hair Removal Products Market – Country Analysis
10.1 Overview
10.1.1.1 Brazil: South & Central America Hair Removal Products Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Brazil: South & Central America Hair Removal Products Market, By Product Type
10.1.1.1.2 Brazil: South & Central America Hair Removal Products Market, by End User
10.1.1.1.3 Brazil: South & Central America Hair Removal Products Market, by Distribution Channel
10.1.1.2 Argentina: South & Central America Hair Removal Products Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Argentina: South & Central America Hair Removal Products Market, By Product Type
10.1.1.2.2 Argentina: South & Central America Hair Removal Products Market, by End User
10.1.1.2.3 Argentina: South & Central America Hair Removal Products Market, by Distribution Channel
10.1.1.3 Rest of South and Central America: South & Central America Hair Removal Products Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Rest of South and Central America: South & Central America Hair Removal Products Market, By Product Type
10.1.1.3.2 Rest of South and Central America: South & Central America Hair Removal Products Market, by End User
10.1.1.3.3 Rest of South and Central America: South & Central America Hair Removal Products Market, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 New Product Development
11.3 Merger and Acquisition
12. Company Profiles
12.1 Reckitt Benckiser Group Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Oriflame Holding AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 The Procter & Gamble Co
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips NV
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Revitol Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 American International Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Organoids Market Segmentation
Table 2. North America Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 3. North America Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Application
Table 4. North America Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Source
Table 5. North America Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 6. US Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 7. US Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 8. US Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 9. US Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 10. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 11. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 12. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 13. Canada Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 14. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 15. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 16. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 17. Mexico Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 18. Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 19. Europe Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Application
Table 20. Europe Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Source
Table 21. Europe Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 22. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 23. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 24. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 25. Germany Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 26. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 27. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 28. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 29. UK Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 30. France Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 31. France Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 32. France Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 33. France Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 34. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 35. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 36. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 37. Italy Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 38. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 39. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 40. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 41. Spain Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 42. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 43. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 44. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 45. Rest of Europe Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 46. Asia Pacific Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 47. Asia Pacific Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Application
Table 48. Asia Pacific Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Source
Table 49. Asia Pacific Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 50. China Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 51. China Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 52. China Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 53. China Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 54. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 55. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 56. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 57. Japan Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 58. India Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 59. India Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 60. India Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 61. India Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 62. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Organ Type
Table 63. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 64. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 65. Australia Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 66. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 67. South Korea Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 68. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 69. South Korea Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 70. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) –Organ Type
Table 71. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 72. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) Source
Table 73. Rest of Asia Pacific Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 74. Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 75. Middle East & Africa Organoids Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 76. Middle East & Africa Organoids Market Revenue and Forecast To 2030 (US$ Mn) – Source
Table 77. Middle East & Africa Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 78. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 79. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 80. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 81. Saudi Arabia Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 82. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 83. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 84. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 85. UAE Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 86. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 87. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 88. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 89. South Africa Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 90. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 91. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 92. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 93. Rest of Middle East & Africa Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 94. South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 95. South & Central America Organoids Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 96. South & Central America Organoids Market Revenue and Forecast To 2030 (US$ Mn) – Source
Table 97. South & Central America Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 98. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 99. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 100. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 101. Brazil Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 102. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 103. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 104. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 105. Argentina Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 106. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 107. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 108. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 109. Rest of South & Central America Organoids Market Revenue And Forecast To 2030 (US$ Mn) – Type
Table 110. Organic Developments Done by Companies
Table 111. Inorganic Developments Done by Companies
Table 112. Glossary of Terms, Organoids Market

LIST OF FIGURES

Figure 1. Organoids Market Segmentation, By Geography
Figure 2. North America – PEST Analysis
Figure 3. Europe – PEST Analysis
Figure 4. Asia Pacific – PEST Analysis
Figure 5. South & Central America – PEST Analysis
Figure 6. Middle East & Africa – PEST Analysis
Figure 7. Organoids Market – Key Industry Dynamics
Figure 8. Impact Analysis of Drivers and Restraints
Figure 9. Organoids Market Revenue (US$ Mn), 2022 – 2030
Figure 10. Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
Figure 11. Stomach: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Intestine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Liver: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Pancreas: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Lung: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Brain: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Kidney: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Organoids Market Revenue Share, by Application 2022 & 2030 (%)
Figure 20. Developmental Biology: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Disease Pathology of Infectious Disease: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Regenerative Medicine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Drug Toxicity and Efficacy Testing: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Drug Discovery and Personalized Medicine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Others: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Organoids Market Revenue Share, by Source 2022 & 2030 (%)
Figure 27. Pluripotent Stem Cells: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Organ-specific Adult Stem Cells: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Organoids Market Revenue Share, by Type 2022 & 2030 (%)
Figure 30. Instruments: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Consumables: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Services: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. Organoids Market, 2022 ($Mn)
Figure 34. North America Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 35. North America Organoids Market, By Key Countries, 2022 And 2030 (%)
Figure 36. US Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 37. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 38. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 39. Europe Organoids Market, By Geography, 2022 ($Mn)
Figure 40. Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 41. Europe Organoids Market, By Key Countries, 2022 And 2030 (%)
Figure 42. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 43. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 44. France Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 45. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 46. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 47. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 48. Organoids Market, By Geography, 2022 ($Mn)
Figure 49. Asia Pacific Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 50. Asia Pacific Organoids Market, By Key Countries, 2022 And 2030 (%)
Figure 51. China Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 52. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 53. India Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 54. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 55. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 56. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. Organoids Market, By Geography, 2022 And 2030 ($Mn)
Figure 58. Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Middle East & Africa Organoids Market, By Key Countries, 2022 And 2030 (%)
Figure 60. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 62. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 63. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 64. Organoids Market, By Geography, 2022 ($Mn)
Figure 65. South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 66. South & Central America Organoids Market, By Key Countries, 2022 and 2030 (%)
Figure 67. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 68. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 69. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 70. Pre & Post Covid-19 Impact
Figure 71. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies – Organoids Market
– STEMCELL Technologies Inc
– Cellesce Ltd
– Hubrecht Organoid Technology
– Definigen
– Organoid Therapeutics
– PeproTech, Inc
– Thermo Fisher Scientific Inc
– Corning Inc
– Merck KGaA
– InSphero.

Reviews

There are no reviews yet.

Be the first to review “Organoids Market Size and Forecasts (2020 – 2030)”